Big Pharma’s Secret Plan to Restrict Supply to Canadian Pharmacies
Friday, March 27th, 2009
With a law to permit drug purchases from Canadian pharmacies expected to pass later this year, drugmakers are planning to fight back by retaliating against those Canadian pharmacies that choose to sell to Americans.
In the past, Big Pharma has sent letters to Canadian pharmacies telling them they would no longer receive quantity discounts if they sold drugs to U.S. consumers. These measures have been successful in bumping up the prices charged to U.S. consumers — but Americans still save an average of more than 50 percent by buying Canadian.
Word around the pharmaceutical industry is that drugmakers are plotting behind closed doors about how to respond to the Canadian pharmacy issue after the bill is passed. Will they clamp down even harder on Canadian pharmacies by restricting supplies? If they do, how will the FDA respond to what would clearly be an attempt to undermine the law?
It should definitely be interesting to watch. You can be sure that Big Pharma will do everything in its power to protect its double-digit profit margins.

A just-released study by the Fraser Institute confirms that brand-name drugs are much cheaper in Canada than the United States. It also shows the price difference has increased in recent years.
The Canadian Broadcasting Corporation (CBC) has produced an